Christopher Keenan

Investor Relations Contact chez PLIANT THERAPEUTICS, INC.

Health Technology

Electronic Technology

Consumer Services

Profil

Mr. Christopher Keenan is a VP-Investor Relations & Corporate Communications at Pliant Therapeutics, Inc. and a Director-Investor Relations at Corning, Inc. Mr. Keenan was previously employed as a Vice President-Investor Relations & Communications by CytomX Therapeutics, Inc. He received his undergraduate degree from Kenyon College.

Postes actifs de Christopher Keenan

Sociétés	Poste	Début
PLIANT THERAPEUTICS, INC.	Investor Relations Contact	01/11/2020
CORNING INCORPORATED	Investor Relations Contact	-

Tous les postes actifs de Christopher Keenan

Anciens postes connus de Christopher Keenan

Sociétés	Poste	Fin
CYTOMX THERAPEUTICS, INC.	Investor Relations Contact	01/10/2020

Voir l'expérience en détail de Christopher Keenan

Formation de Christopher Keenan

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Christopher Keenan

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
Corning, Inc. Corning, Inc. Electronic ComponentsElectronic Technology Manufactures specialty glass and ceramics	Electronic Technology
Kenyon College Kenyon College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
CytomX Therapeutics, Inc. CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer	Health Technology
Pliant Therapeutics, Inc. Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis	Health Technology